Boston Scientific Earnings Preview: Revenue, Earnings Expected to Fall from Previous Quarter

Get ready for Boston Scientific BSX earnings! Don't be the last to know: The company announces its next round of earnings this Monday, July 18, 2011.

No time to prep before Monday's announcement? Don't worry. Here is your everything-that-matters guide to Boston Scientific's second quarter earnings report.

Let's Do the Numbers:

Analysts are looking ahead to a positive EPS reading of 8 cents per share and revenues of $1.94 billion. We'll have to wait for Monday to see if Boston Scientific falls in line with analyst expectations and reports an estimated increase in both EPS and revenue from the year-ago quarter.

Here's how the company's reported EPS has stacked up against analyst estimates in the past:

Quarter	Q1	Q4	Q3	Q2
EPS Estimate	4 cents	10 cents	6 cents	3 cents
EPS Actual	14 cents	20 cents	12 cents	6 cents

Stock Performance:

At last check, shares of Boston Scientific were trading at $7.28. Shares are down 3.8% year to date.

Average Stock Rating:

The average rating by analysts for Boston Scientific is a Hold. The strength of this rating has declined slightly over the past three months.

Competitors:

Wondering how Boston Scientific compares to rivals in the same sector? Here are a few of the company's peers.

• Abbott Laboratories ABT: Hold with a $0.91 recent quarter EPS
• Johnson & Johnson JNJ: Moderate Buy with a $1.35 recent quarter EPS

Boston Scientific is in the medical products industry, which has experienced price/earnings growth of 1.4%.

Finally, a description of the main business areas of the company, in case you need a little refresher: Boston Scientific, Inc. offers medical devices used in interventional cardiology, cardiac rhythm management, peripheral interventions, endoscopy, gynecology, electrophysiology, neurovascular intervention and neuromodulation.

Take Action:

Now that you have reviewed all the numbers, be ready to move if the upcoming Boston Scientific earnings report has any surprises. Also, come back to Benzinga after the announcement for a full recap and a guide to your next steps.

• To see up-to-date news on Boston Scientific, click here
• To see other trading ideas, click here
• To see other company earnings recaps, click here